Showing 641 - 660 results of 33,082 for search '(( 5 ((non decrease) OR (mean decrease)) ) OR ( 50 ((mg decrease) OR (a decrease)) ))', query time: 0.66s Refine Results
  1. 641
  2. 642
  3. 643
  4. 644

    Expression of cytokines by CD3+ infiltration in PDAC. by Gerik W. Tushoski-Alemán (17951809)

    Published 2024
    “…<p>(A) Heatmap of 41 analytes in PDAC (n = 55) and non-PDAC tissue (Pancreatitis (n = 12), IPMN (n = 3), Other (n = 6)), expression levels were normalized to protein concentration (B, C): Spearman correlation analysis of IL-1B (r = -0.3704, p = 0.0187) and IL-2 (r = -0.4275, p = 0.0074) show decreased concentrations were significantly associated with increased CD3+ infiltration. …”
  5. 645

    Expression of cytokines by CD8+ infiltration in PDAC. by Gerik W. Tushoski-Alemán (17951809)

    Published 2024
    “…<p>(A) Expression of 41 analytes in PDAC (n = 58) and non-PDAC (Pancreatitis (n = 13), IPMN (n = 4), Other (n = 7)) expression is normalized to protein concentration (B) Spearman correlation analyses showing increased expression of IL-1B significantly associated with decreased CD8+ infiltration (r = -0.4299, p = 0.0045). …”
  6. 646
  7. 647
  8. 648
  9. 649

    DataSheet_2_A cyclic peptide-based PROTAC induces intracellular degradation of palmitoyltransferase and potently decreases PD-L1 expression in human cervical cancer cells.docx by Yu-Ying Shi (15975992)

    Published 2023
    “…Introduction<p>Our previous research has found that degradation of palmitoyltransferase in tumor cells using a linear peptide PROTAC leads to a significant decrease in PD-L1 expression in tumors. …”
  10. 650

    DataSheet_1_A cyclic peptide-based PROTAC induces intracellular degradation of palmitoyltransferase and potently decreases PD-L1 expression in human cervical cancer cells.docx by Yu-Ying Shi (15975992)

    Published 2023
    “…Introduction<p>Our previous research has found that degradation of palmitoyltransferase in tumor cells using a linear peptide PROTAC leads to a significant decrease in PD-L1 expression in tumors. …”
  11. 651
  12. 652
  13. 653

    Nimodipine does not decrease markers of neuritic dystrophy in 5XFAD transgenic mice. by Katherine R. Sadleir (12035242)

    Published 2022
    “…Similarly, BACE1, LAMP1 and LC3B-II/ LC3B-I were also increased in nimodipine-treated 5XFAD compared to nimodipine treated non-transgenic mice, indicating that nimodipine did not decrease the accumulation of these dystrophic neurite marker proteins. …”
  14. 654
  15. 655
  16. 656
  17. 657

    Table 5_Road transportation is associated with decreased intestinal motility in horses.docx by Sharanne L. Raidal (3097719)

    Published 2025
    “…Signalment and past travel history were not predictive of intestinal motility, but horses with unknown or no prior travel history (mean 12.8, 95%CI 8.2-17.4 nmol/L) had higher cortisol concentrations prior to departure than horses known to have travelled previously (7.9, 5.8−9.9 nmol/L, p = 0.023).…”
  18. 658

    Density plots of normalised consumer final power (PC) for the six example networks, shown over decreasing ratios of mean consumer to mean resource potential, . by Natalie Davis (8556036)

    Published 2020
    “…<p>Each plot shows the density for the normalised consumer final power at = 0.75, 0.5, and 0.25, from left to right, as the ratio decreases due to increased resource flow during the simulation. …”
  19. 659
  20. 660